智通财经APP讯，高视医疗(02407)公布，公司获受托人告知，自2024年11月19日起至2025年1月23日止，受托人已动用约1278万港元于市场上按每股约9.67港元的平均代价购买合共132.24万股股份(占于本公告日期已发行股份总数约0.89%)。截至本公告日期，受托人已根据本计划合共动用约1792万港元购买合共179.96万股股份(占于本公告日期已发行股份总数约1.22%)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.